🇺🇸 FDA
Patent

US 7335689

Dihydroxyl compounds and compositions for cholesterol management and related uses

granted A61KA61K31/191A61K31/194

Quick answer

US patent 7335689 (Dihydroxyl compounds and compositions for cholesterol management and related uses) held by Esperion Therapeutics, Inc. expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Esperion Therapeutics, Inc.
Grant date
Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K31/191, A61K31/194, A61K31/20, A61K31/23